Online electrical retailer AO World (AO.) has announced results for its half-year ended 30th September 2018, emphasising “continued revenue growth with total revenue for the period increasing by 9.9% to £404.2m (2017: £368.0m)” and “remain confident of achieving long-term sustainable growth across the group”. The shares have responded, er... currently more than 5% further lower, below 120p. Hmmm…

If you are a proven liar like Steve Sanderson of UK Oil & Gas (UKOG) who won't buy any shares in his own company but wants to ramp them ahead of the next placing what do you do? Easy. Pay Sharetalk (we will interview anyone who pays the fee) to record an interview with the Sith Lord Zak Mir who makes Justin the Clown look like the Spanish Inquisition and ramp away. Today's podcast is a classic bit of Leni-maths as Lyin' Steve explains to a credulous Zak how to value an oil stock and why UK Oil & Gas could be worth hundreds of millions of pounds if not more. Of course Lyin' Steve is talking utter crap as I explained HERE.  Meanwhile enjoy...

Number one is Amazon (again). Number two is Barclays Bank (BARC) again! And the third is explained HERE. Elswhere I explain what it means when I am made an insider and how I have to behave. I look at the bitcoin bloodbath and in that vein at Argo Blockchain (ARGO), Vela (VELA) and the Clem'Chambers spoof Online Blockchain (OBC). I cover Falanx (FLX), Photonstar Led (PSL) and AO World (AO).

Well you can’t say you were not warned! As both Steve Moore and Tom Winnifrith are drinking from the bottle of ouzo supplied by the Global Shorting Conspiracy it falls to me, on behalf of ShareProphets, to say told ya! (I’ll have my little cupful later). It was announced by AIM-listed PhotonStar LED (PSL) a few minutes ago that its wholly-owned subsidiary PhotonStar LED Limited was placed into liquidation. With the remaining business yet to sign a material contract and needing funding, this really is toast.

Fully-listed Telecom Plus (TEP) is a member of the FTSE250 and it announced its interims this morning. The shares are currently up 56p to 1258p, valuing the company at £982 million. With an expected full year dividend of 52p that puts the shares on a dividend yield of 4.13% which appears quite tasty when compared to a bank account. So are they for dividend munchers, or is there something lurking beneath the surface to make me run a mile? Covering the company in the past I was less than convinced, but with fresh eyes let’s take a look.

Our friends at Stockomendation have launched a Crowd Funding Campaign to help grow their business in the UK and into new markets. I like Stockomendation and think the management team, though boorishly Welsh, are strong, committed and have a business model that is interesting. Compared to some of the crap that is Crowdfunded this is bluechip and it has already raised most of its £350,000 target.

TrakM8 (TRAK) served up dismal interims late last week but as I warned then, things could get an awful lot worse. It all depends on how much the bankers at HSBC and panicking and what they are doing about it. TrakM8 needs to fess up to investors and make a statement.

This bearcast is prompted partly by news Purplebricks (PURP) is not telling you about and partly by Malcolm's buy note on Bovis (BVS) earlier and partly on some new housing data out yesterday. Suffice to say Purplebricks is in ever deeper merde, Malcolm Stacey is wrong and there really could be a big fall in UK house prices and volumes and it is just partly linked to Brexit. It is a pin and we know there is a bubble.

A “Trading Update and Revised Dividend Commitment” announcement from telecommunications and related services group KCom (KCOM). The prospective dividend yield was already 6.5% - so I’m guessing it ain’t being revised upwards…

Privately held Immunocore, which forms part of the Neil Woodford estate, has announced some good news: it has signed a deal with Genetech, part of Roche Group, for the development of Immunocore’s IMC-C103C drug aimed at targeting the MAGE-A4 protein (Melanoma-Associated Antigen A4). The really good news is that Genetech is to hand over $100 million in upfront and near-term milestone payments, and upon establishing proof-of-concept there is an option to co-develop the treatment or license the treatment to Genetech for royalty and milestone payments. Needless to say, Woodford Patient Capital Trust (WPCT) rushed out a statement too...

Hello, Share diggers. There are niggles that house builders will be hobbled by Brexit. I can't see it myself. We need housing and homes are still in short supply. The Government has not said it will ease back on its generous incentives for builders when we leave the EU, so if the usual rules of supply and demand apply - and they’re always pretty powerful - then firms which build should, well, build their share prices while unemployment is low and interest rates are still modest...

Writing on Prime People (PRP) in the summer, I concluded I’d want further detail of stated ‘encouraging activity’ but on the watchlist and the braver might consider a small, speculative buy. Now half-year results from this ‘real estate & built environment, energy & environmental and insight & analytics sectors’ specialist recruitment group…

AIM-listed and almost out of cash Haydale (HAYD) has issued yet another RNS Reach, this time to tell us that it has signed an exclusive deal with TKS Siampress Management for an anti-counterfeiting product. Whoopie doo – but there are, predictably, no numbers offered. And an RNS Reach is for news which is, effectively, not material.

AIM-listed former Rob Terry favourite Imaginatek (IMTK) published its half year results to the end of September this morning – what a dog’s breakfast! Of course, the majority of the period was under the old management so as much as I would like to point the finger at new CEO Angus Forrest, that would be grossly unfair. Indeed, judging by the balance sheet he’s done very well to have kept the grim reaper at bay – and he nearly pulled off a dream proposal to bring the very saintly Vin Murria in….but that fell apart. The shares as I write are up just 10% at 1.375p in the middle, having peaked earlier in the day at 2.25p in an initial burst of enthusiasm. It looks to me like the market has taken fright at the balance sheet.

The Mrs tuned the radio and the awful BBC tortured me all morning reaching peak torture during Woman's Hour. It was strangely addictive. It is what Hell will be like when I go there on the day of judgement. Tearing myself away I look at Sound Energy (SOU), Highlands Natural Resources (HNR), TrakM8 (TRAK) and Imaginatik (IMTK)

The EU has had a lot of trouble on its hands, as its members, such as Poland and Hungary, are openly challenging the established order. This time it’s a very serious situation, because Brussels is facing defiance from Italy, the 3rd largest national economy in the eurozone and the 8th largest global economy in terms of nominal GDP. It has a population of over 60 million. It is also a Europhile country and the bloc’s founding member...

CyanConnode (CYAN) has announced that it “has won the 2018 Company of the Year Award for the Global Smart Metering Industry. Frost & Sullivan found CyanConnode's innovation in the Smart Meter Industry highly impressive and recognised that the company has grown from a European pioneer into a Global Leader”. Hmmm, but wasn’t it last commented here a ‘pleasing’ fundraising “to fund future growth”? Nope. ‘Pleasing’ board participation? Er…?

I know. I know.  The price of coke and also of hookers is going up. I blame Brexit.  What we need are frictionless borders so we can import more of both from Albania to keep the City boys happy. Pro tem that means brokers need to hold their noses (so to speak) and act for anyone.  Even proven shysters like Tomco (TOM).

Do you remember when shares in Sound Energy (SOU) were 80p+ and some commentators thought they would multi-bag from there?  I warned you that this was a stock built on spinning plates and that, one day, reality would cause pain and misery for shareholders. That day is today, the shares are down by 29% at just 17p. But could it get even worse?  You bet it could.

Two caveats. Firstly, the analyst producing this note is Dr Michael Green who as PR man to the fraud Sefton (SER) earned a fat wedge protecting that fraud by, inter alia, masterminding a dirty tricks campaign against myself and Dan Levi.  He is a motherfucker with no place in financial services and he should be cold shouldered by anyone with any sense of morality. Secondly, Align is a paid for research provider. Notwithstanding that I reckon Wishbone Gold (WSBN) shares, which we own and bought more of at 0.1p, are very cheap.  So here is the Align research. The morally bankrupt Green who Align should fire on principle, opines: